Alpha 2.0
Login Register
» Authors » A Buonadonna

A Buonadonna

Explore the profile of A Buonadonna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 2135
Followers 0
Related Specialties
Oncology
General Surgery
Pharmacology
Top 10 Co-Authors
P G Casali
S Frustaci
A Gronchi
A P Dei Tos
V Ferraresi
S Stacchiotti
G Grignani
J V M G Bovee
A M Frezza
P Reichardt
Published In
Ann Oncol
Tumori
J Clin Oncol
Br J Cancer
Cancer Radiother
Affiliations
Soon will be listed here.
Recent Articles
1.
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
Vanzulli A, Vigorito R, Buonomenna C, Palmerini E, Quagliuolo V, Broto J, et al.
ESMO Open . 2025 Mar; 10(3):104299. PMID: 40056850
Background: We report the results of the pre-planned secondary analysis of radiologic responses (RRs) of ISG-STS 1001, a randomized trial comparing anthracycline + ifosfamide (AI) versus histology-tailored (HT) neoadjuvant chemotherapy...
2.
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA)
Di Nardo P, Basile D, Siciliano A, Pelizzari G, Corvaja C, Buriolla S, et al.
Dig Liver Dis . 2023 Aug; 56(5):786-794. PMID: 37586908
Background: The optimal strategy for second-line (IIL) treatment in KRAS wt metastatic colorectal cancer (mCRC) is not determined yet. Methods: A random-effect NMA of phase II/III RCTs was conducted to...
3.
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO
Rossini D, Boccaccino A, Sbrana A, Daniel F, Borelli B, Raimondi A, et al.
ESMO Open . 2021 Oct; 6(6):100293. PMID: 34689001
Background: TRIBE and TRIBE-2 studies demonstrated higher benefit from FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan)/bevacizumab compared with FOLFIRI (fluorouracil, leucovorin, and irinotecan) or FOLFOX/bevacizumab as an upfront option for metastatic...
4.
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Casali P, Blay J, Abecassis N, Bajpai J, Bauer S, Biagini R, et al.
Ann Oncol . 2021 Sep; 33(1):20-33. PMID: 34560242
No abstract available.
5.
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Strauss S, Frezza A, Abecassis N, Bajpai J, Bauer S, Biagini R, et al.
Ann Oncol . 2021 Sep; 32(12):1520-1536. PMID: 34500044
No abstract available.
6.
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gronchi A, Miah A, Dei Tos A, Abecassis N, Bajpai J, Bauer S, et al.
Ann Oncol . 2021 Jul; 32(11):1348-1365. PMID: 34303806
No abstract available.
7.
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies
Marmorino F, Rossini D, Lonardi S, Moretto R, Zucchelli G, Aprile G, et al.
Ann Oncol . 2019 Oct; 30(12):1969-1977. PMID: 31573612
Background: The phase III TRIBE and TRIBE2 studies randomized metastatic colorectal cancer patients to first-line FOLFOXIRI/bevacizumab or a doublet (FOLFIRI or FOLFOX)/bevacizumab. The studies demonstrated a significant benefit from the...
8.
Erratum to: "Multidisciplinary treatment approach for primary thyroid spindle cell sarcoma: A case report" [Cancer Radiother. 23 (2019) 46-9]
Navarria F, Gigante M, Mascarin M, Italia F, Barresi L, Barzan L, et al.
Cancer Radiother . 2019 Apr; 23(2):173-174. PMID: 30962080
No abstract available.
9.
Multidisciplinary treatment approach for primary thyroid spindle cell sarcoma: A case report
Navarria F, Gigante M, Mascarin M, Italia F, Barresi L, Barzan L, et al.
Cancer Radiother . 2019 Jan; 23(1):46-49. PMID: 30642779
A 25-year-old female with high-grade spindle cell sarcoma of the thyroid persistent after thyroidectomy performed at another hospital was referred to our institute. Chemotherapy followed by surgery with intraoperative radiotherapy...
10.
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Casali P, Bielack S, Abecassis N, Aro H, Bauer S, Biagini R, et al.
Ann Oncol . 2018 Oct; 29(Suppl 4):iv79-iv95. PMID: 30285218
No abstract available.